Antonio Berlanga Ruiz
Antonio holds a Master’s in Business Administration and is Member of the Governing Council Committee of the City of Madrid
Learn More about Antonio
Rafael Zurita, MSc
Rafael is our General Manager, and is responsible for driving the company's growth as an agile and adaptive clinical development firm.
Read More About Rafael
Paul Bishop
Paul began his educational journey at the University of Virginia, where he graduated with a Bachelor of Arts in Biology.

Learn More About Paul
Michael Gierend, DVM, Ph.D.
A Founding Partner of PSNResearch, Michael has served in many leadership capacities since our inception in 1997.
See Michael's Expertise
Dr. Ignazio di Giovanna
Ignazio holds his BSc in Physiology and P.hD. in Biophysics from the University of London and joined the Pharmaceutical Industry in 1986.
See Ignazio's Accomplishments
Rasmus Nelund
Rasmus bring over 20 years of experience as a leader in the international life science industry.
Read About Rasmund
Frédéric Mistretta
Frédéric is the co-leader of the AFCROs Real World Studies working group.
Read More about Frédéric
Odette Jochems, M.D.
Odette brings over 35 years of experience with the Dutch healthcare system and its regulatory bodies.

Read About Odette
Lyle Camblos
Lyle’s clinical research expertise extends from novel agents in orphan status phase I trials to post-marketing safety, surveillance, and oversight.
Learn More About Lyle
Pino Fioravanti, M.D.
Pino Fioravanti is graduated specialist in Endocrinology and Metabolic Diseases as well as in Medicine from the University of Rome.
Read More about Pino

IctalCare launches CE-marked M1 Epilepsy Alarm

IctalCare's success story results from our contribution to their clinical development process: protocol writing, monitoring, data management, statistics, and reporting
Learn more

Arzerra EMA/FDA approved following successful pivotal Phase III trial

Planning, conduct and reporting of a pivotal, phase 3 clinical trial in chronic lymphocytic leukemia (CLL) - 225 patients, 13 countries - resulted in full approval.
Speak With This Partner

Paedriatric Investigational Plan complete and approved for METFIZZ

Our regulatory/medical affairs team has been awarded a EU’s Seventh Framework Programme for Research (FP7) grant for the Phase III study.
Read More